UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Human gene therapy, ISSN 1043-0342, 05/2018, Volume 29, Issue 5, pp. 585 - 601
Research Articles | gene therapy | multiple myeloma | BCMA | CAR | adoptive cell therapy | immunotherapy | Genetics & Heredity | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Hematologic Neoplasms - therapy | Humans | Hematologic Neoplasms - pathology | Tumor Necrosis Factor Receptor Superfamily, Member 9 - genetics | Multiple Myeloma - therapy | CD3 Complex - genetics | T-Lymphocytes - drug effects | Lentivirus - genetics | Gene Expression Regulation, Neoplastic - drug effects | Cytotoxicity, Immunologic - drug effects | B-Cell Maturation Antigen - antagonists & inhibitors | B-Cell Maturation Antigen - immunology | Immunotherapy, Adoptive | Tumor Necrosis Factor Receptor Superfamily, Member 9 - immunology | Xenograft Model Antitumor Assays | Receptors, Chimeric Antigen - therapeutic use | Multiple Myeloma - pathology | Animals | Receptors, Chimeric Antigen - immunology | CD3 Complex - immunology | Cell Line, Tumor | T-Lymphocytes - immunology | Hematologic Neoplasms - genetics | Mice | Hematologic Neoplasms - immunology | Multiple Myeloma - genetics | Biotechnology | Animal models | Intravenous administration | Leukemia | Multiple myeloma | Lymphocytes T | Receptors | Lymphocytes | Peripheral blood | Antigens | Chronic lymphatic leukemia | CD137 antigen | Hematology | Maturation | Tumor cells | Therapeutic applications | Pharmacology | Tumor cell lines | Lymphatic leukemia | Lymphoma | Molecular chains | Burkitt's lymphoma | Chimeric antigen receptors | Lymphocytes B | Mantle cell lymphoma | Plasma cells | Tumors | Index Medicus
Journal Article
2017, 9th edition., ISBN 9780815345053, xx, 904 pages
Book
Nature reviews. Immunology, ISSN 1474-1733, 07/2009, Volume 9, Issue 7, pp. 491 - 502
Life Sciences & Biomedicine | Immunology | Science & Technology | B-Cell Maturation Antigen - immunology | Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology | Tumor Necrosis Factor Receptor-Associated Peptides and Proteins - immunology | Humans | Toll-Like Receptors - immunology | Tumor Necrosis Factor Ligand Superfamily Member 13 - metabolism | Tumor Necrosis Factor Receptor-Associated Peptides and Proteins - metabolism | Transmembrane Activator and CAML Interactor Protein - metabolism | Signal Transduction - immunology | Lymphocyte Activation - immunology | Animals | B-Cell Activating Factor - metabolism | B-Cell Maturation Antigen - metabolism | B-Lymphocyte Subsets - metabolism | Autoimmunity - immunology | Immune Tolerance - immunology | B-Cell Activating Factor - immunology | B-Lymphocyte Subsets - immunology | Ligands | Toll-Like Receptors - metabolism | Transmembrane Activator and CAML Interactor Protein - immunology | Autoimmunity | Physiological aspects | B cells | Research | Tumor necrosis factor | Risk factors | Index Medicus
Journal Article
The Journal of clinical investigation, ISSN 0021-9738, 05/2017, Volume 127, Issue 5, pp. 1651 - 1663
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Toll-Like Receptor 9 - genetics | Male | T-Box Domain Proteins - immunology | G1 Phase Cell Cycle Checkpoints - immunology | MAP Kinase Signaling System - immunology | Toll-Like Receptor 9 - immunology | Cell Differentiation - genetics | Interleukins - genetics | MAP Kinase Signaling System - genetics | Interleukins - immunology | B-Cell Activating Factor - immunology | Female | CD40 Antigens - genetics | Interferon-gamma - genetics | Cell Line | DNA - immunology | p38 Mitogen-Activated Protein Kinases - genetics | p38 Mitogen-Activated Protein Kinases - immunology | T-Box Domain Proteins - genetics | G1 Phase Cell Cycle Checkpoints - genetics | Receptors, Antigen, B-Cell - immunology | Mice, Knockout | Cell Differentiation - immunology | Animals | B-Lymphocytes - immunology | B-Cell Activating Factor - genetics | Interferon-gamma - immunology | Antigens - immunology | Receptors, Antigen, B-Cell - genetics | Mice | CD40 Antigens - immunology | Antigens | DNA | Cytokine receptors | TLR9 | Cellular signal transduction | Research | B cells | CD27 antigen | CD40 antigen | Laboratories | B-cell receptor | Kinases | Genotype & phenotype | Mitochondria | Cell activation | Lymphocytes | Cell cycle | Interleukin 21 | Toll-like receptors | Deoxyribonucleic acid--DNA | Immunization | Cell survival | Cytokines | Cell division | T cell receptors | Survival | TLR9 protein | Immune response (humoral) | Medicine | Lymphocytes B | BLyS protein | Ligands | Interferon | Regulation | Autoimmune diseases | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
5.
Full Text
B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma
The Journal of clinical investigation, ISSN 0021-9738, 03/2019, Volume 129, Issue 6, pp. 2210 - 2221
Cancer immunotherapy | Oncology | Clinical Trials | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Cyclophosphamide - administration & dosage | Multiple Myeloma - mortality | Humans | Middle Aged | Neoplasm Proteins - immunology | Male | Multiple Myeloma - immunology | Lymphocyte Depletion | Cyclophosphamide - adverse effects | T-Lymphocytes - transplantation | Multiple Myeloma - therapy | Adult | Female | T-Lymphocytes - pathology | Neoplasm Proteins - genetics | B-Cell Maturation Antigen - immunology | Autografts | Transduction, Genetic | Immunotherapy, Adoptive | Survival Rate | Disease-Free Survival | Receptors, Chimeric Antigen - immunology | Receptors, Chimeric Antigen - genetics | T-Lymphocytes - immunology | Aged | Multiple Myeloma - genetics | Antigens | Chemotherapy | Cyclophosphamide | Pharmaceutical industry | T cells | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Nature medicine, ISSN 1078-8956, 10/2018, Volume 24, Issue 10, pp. 1499 - 1503
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Leukemia - pathology | Humans | Receptors, Antigen, T-Cell - therapeutic use | Leukemia - drug therapy | Receptors, Chimeric Antigen | Male | Drug Resistance, Neoplasm - immunology | Cell- and Tissue-Based Therapy | Epitopes - immunology | Young Adult | B-Lymphocytes - immunology | Leukemia - immunology | Antigens, CD19 - therapeutic use | Adult | Receptors, Antigen, T-Cell - immunology | T-Lymphocytes - immunology | Antigens, CD19 - immunology | Case studies | Complications and side effects | Antigen receptors, T cell | Chemotherapy | Receptors | Relapse | Leukemia | T cells | Health aspects | Cancer | Chimeric antigen receptors | Infusion | CD19 antigen | Lymphocytes B | Lymphocytes | CAR gene | Masking | Lymphocytes T | Index Medicus
Journal Article
Immunity (Cambridge, Mass.), ISSN 1074-7613, 09/2012, Volume 37, Issue 3, pp. 524 - 534
Humans | Interleukin-17 - immunology | Male | Receptors, Antigen, T-Cell, gamma-delta - genetics | Flow Cytometry | T-Lymphocytes - metabolism | Algal Proteins - immunology | Base Sequence | Female | Phycoerythrin - metabolism | B-Lymphocytes - metabolism | Amino Acid Sequence | Phycoerythrin - immunology | Receptors, Antigen, T-Cell, gamma-delta - metabolism | Mice, Inbred C57BL | Cells, Cultured | Interleukin-17 - genetics | Mice, Transgenic | Receptors, Antigen, T-Cell, gamma-delta - immunology | Antigens - metabolism | Binding Sites - genetics | Protein Binding - immunology | Interleukin-17 - metabolism | Animals | B-Lymphocytes - immunology | Antigens - immunology | Mice, Inbred NOD | T-Lymphocytes - immunology | Mice | Kinetics | Algal Proteins - metabolism | Index Medicus
Journal Article
The Journal of immunology (1950), ISSN 0022-1767, 02/2015, Volume 194, Issue 3, pp. 911 - 920
Humans | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Intracellular Space | Lymphoma, B-Cell - genetics | CD28 Antigens - metabolism | T-Cell Antigen Receptor Specificity - genetics | T-Cell Antigen Receptor Specificity - immunology | Lymphoma, B-Cell - immunology | Antigens, Surface - metabolism | CD8-Positive T-Lymphocytes - metabolism | Gene Order | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Genes, Reporter | Lymphoma, B-Cell - drug therapy | Recombinant Proteins - metabolism | Antigens, CD20 - immunology | T-Lymphocyte Subsets | Gene Expression | Lymphoma, B-Cell - metabolism | Transduction, Genetic | Receptors, Antigen, T-Cell - metabolism | Signal Transduction | Lymphocyte Activation | Rituximab | Immunophenotyping | CD28 Antigens - immunology | Recombinant Proteins - genetics | Antigens, CD20 - metabolism | CD3 Complex - metabolism | Leukemia, Lymphocytic, Chronic, B-Cell - metabolism | CD3 Complex - immunology | Cell Line, Tumor | Protein Binding | Receptors, Antigen, T-Cell - genetics | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | CD8-Positive T-Lymphocytes - immunology | Antigens, Surface - immunology | Cytokines - biosynthesis | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Cytotoxicity, Immunologic | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 02/2015, Volume 33, Issue 6, pp. 540 - 549
Life Sciences & Biomedicine | Oncology | Science & Technology | Cyclophosphamide - administration & dosage | Immunotherapy, Adoptive - methods | Lymphoma, Large B-Cell, Diffuse - drug therapy | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Combined Modality Therapy | Vidarabine - analogs & derivatives | T-Lymphocytes - transplantation | Lymphoma, Large B-Cell, Diffuse - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, B-Cell - immunology | Lymphoma, Large B-Cell, Diffuse - immunology | Adult | Female | Receptors, Antigen, T-Cell - immunology | T-Lymphocytes - immunology | Aged | Vidarabine - administration & dosage | Transplantation Conditioning - methods | Antigens, CD19 - immunology | Lymphoma, B-Cell - drug therapy | Index Medicus | Hema17 | Hema8 | Hema16 | To6 | ORIGINAL REPORTS | Hema9
Journal Article